Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Life Science Alliance|March 24, 2022
Ribosomal protein L5 facilitates rDNA-bundled condensate and nucleolar assemblyHaruka Matsumori, Kenji Watanabe, Hiroaki Tachiwana, et al.
Pediatric Blood & Cancer|October 21, 2015
Preserved High Probability of Overall Survival with Significant Reduction of Chemotherapy for Myeloid Leukemia in Down Syndrome: A Nationwide Prospective Study in JapanTakashi Taga, Tomoyuki Watanabe, Daisuke Tomizawa, et al.
Blood|April 8, 2026
Polycomb repressive complex 2 insufficiency underlies myeloid leukemia in Down syndromeYutaro Suzuki, Yaeko Nakajima-Takagi, Motohiko Oshima, et al.
Blood|March 14, 2013
Clonal selection in xenografted TAM recapitulates the evolutionary process of myeloid leukemia in Down syndromeSatoshi Saida, Ken-ichiro Watanabe, Aiko Sato-Otsubo, et al.
Leukemia|February 16, 2021
Post-induction MRD by FCM and GATA1-PCR are significant prognostic factors for myeloid leukemia of Down syndromeTakashi Taga, Shiro Tanaka, Daisuke Hasegawa, et al.
Ejhaem|July 18, 2022
Dyserythropoietic anaemia with an intronic GATA1 splicing mutation in patients suspected to have Diamond-Blackfan anaemiaAkie Kobayashi, Ryusei Ohtaka, Tsutomu Toki, et al.
Genes, Chromosomes & Cancer|July 22, 2014
Gene alterations involving the CRLF2-JAK pathway and recurrent gene deletions in Down syndrome-associated acute lymphoblastic leukemia in JapanIsamu Hanada, Kiminori Terui, Fumika Ikeda, et al.
Blood|January 21, 2012
Extensive gene deletions in Japanese patients with Diamond-Blackfan anemiaMadoka Kuramitsu, Aiko Sato-Otsubo, Tomohiro Morio, et al.
Cancer Science|August 7, 2019
Integrated genetic and epigenetic analysis revealed heterogeneity of acute lymphoblastic leukemia in Down syndromeYasuo Kubota, Kumiko Uryu, Tatsuya Ito, et al.
Cancer Medicine|July 16, 2019
Resistance of t(17;19)-acute lymphoblastic leukemia cell lines to multiagents in induction therapyAtsushi Watanabe, Takeshi Inukai, Keiko Kagami, et al.
Pageof 7